Tymofiyiv V. V., Kryzhanivska A. Y., Diakiv I. B.
ANALYSIS OF INCIDENCE OF STAGE I-II CERVICAL CANCER DURING THE COVID-19 PANDEMIC
Show/Download
About the author:
Tymofiyiv V. V., Kryzhanivska A. Y., Diakiv I. B.
Heading:
SOCIAL MEDICINE, ECONOMY AND HEALTH CARE ORGANIZATION
Type of article:
Scientific article
Annotation:
Today, malignant tumors of the cervix are an urgent problem in oncology. Cervical cancer occupies one of the leading places in terms of prevalence (4th position) and mortality (4th position) among the female population. Cervical cancer is one of the most common cancers in women, accounting for approximately 6.5% of all cancers in women worldwide. The average age of patients is 35-45 years, that is, reproductive age. Despite considerable advances in diagnosis, prevention and treatment, the disease is still fatal for many women, especially in low-income countries. The prognosis of the disease depends on the stage of the condition, the level of differentiation of the tumor, the age of the patient, and the damage to the lymph nodes. Considering these factors, this disease remains a subject of interest for scientists to identify new prognostic factors for the course of the disease and the possibility of influencing them. The research is based on the results of observation of cervical cancer patients from 2018 to 2022 and the years when the whole world was faced with the coronavirus epidemic led to the development of severe acute respiratory syndrome coronavirus-2 (SARSCoV-2 [COVID-19]). Since the beginning of the pandemic, fewer patients with earlystage cancer have been identified. Many people are avoiding diagnosis due to the COVID-19 outbreak. At the same time, more people turn to doctors already at a late stage of oncology, and this trend will be observed in the future if research into the early stages of oncology is not intensified, most patients will be diagnosed with neglected cancer.
Tags:
Bibliography:
- Escobar N, Plugge E. Prevalence of human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer in imprisoned women worldwide: A systematic review and meta-analysis. J. Epidemiol. Community Health. 2020;74(1):95-102. DOI: 10.1136/jech-2019- 212557.
- Sherris J, Herdman C, Elias C. Cervical cancer in the developing world. West J. Med. 2001;175:231-233. DOI: 10.1136/ewjm.175.4.231.
- Memon A, Bannister P. Epidemiology of Cervical Cancer. Uterine Cervical Cancer. Cham, Switzerland: Springer; 2019. 299 р.
- The Surveillance, Epidemiology, and End Results (SEER) Program [Internet]. [accessed 2023 Oct 21]. Available from: http://seer.cancer. gov.
- Cancer Research UK [Internet]. [accessed 2023 Oct 21]. Available from: http://info.cancerresearchuk.org.
- Nowakowski A, Cybulski M, Buda I, Janosz I, Olszak-Wąsik K, Bodzek P, et al. Cervical Cancer Histology, Staging and Survival before and after Implementation of Organised Cervical Screening Programme in Poland. PLoS ONE. 2016;11:e0155849. DOI: 10.1371/journal. pone.0155849.
- Sharpless NE. COVID-19 and cancer. Science. 2020;368:1290. DOI: 10.1126/science.abd3377.
Publication of the article:
«Bulletin of problems biology and medicine», 2023 Issue 4, 171, 383-390 pages, index UDC 618.146+616-006.6+616-036.21
